METRONIDAZOLE 1% / MUPIROCIN 2% /- metronidazole 1% / mupirocin 2% / ointment

Pays: États-Unis

Langue: anglais

Source: NLM (National Library of Medicine)

Ingrédients actifs:

MUPIROCIN (UNII: D0GX863OA5) (MUPIROCIN - UNII:D0GX863OA5), METRONIDAZOLE (UNII: 140QMO216E) (METRONIDAZOLE - UNII:140QMO216E)

Disponible depuis:

Sincerus Florida, LLC

Mode d'administration:

TOPICAL

Type d'ordonnance:

PRESCRIPTION DRUG

Statut de autorisation:

unapproved drug other

Résumé des caractéristiques du produit

METRONIDAZOLE 1% / MUPIROCIN 2% /- METRONIDAZOLE 1% / MUPIROCIN 2% /
OINTMENT
SINCERUS FLORIDA, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
METRONIDAZOLE 1% / MUPIROCIN 2%
DIRECTIONS FOR USE
SINCERUS FLORIDA, LLC. ADVERSE REACTIONS
ACTIVE, INACTIVE
NDC 72934- 5151-2 METRONIDAZOLE USP 1% / MUPIROCIN USP 2%, OINTMENT
30GM
METRONIDAZOLE 1% / MUPIROCIN 2% /
metronidazole 1% / mupirocin 2% / ointment
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:729 34-5151
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
MUPIRO CIN (UNII: D0 GX8 6 3OA5) (MUPIROCIN - UNII:D0 GX8 6 3OA5)
MUPIROCIN
2 g in 10 0 g
METRO NIDAZO LE (UNII: 140 QMO216 E) (METRONIDAZOLE - UNII:140 QMO216
E)
METRONIDAZOLE
1 g in 10 0 g
Sincerus Florida, LLC
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END DATE
1
NDC:729 34-5151-
2
30 g in 1 BOTTLE, PUMP; Type 0 : No t a Co mbinatio n
Pro duc t
0 5/14/20 19
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 5/14/20 19
LABELER -
Sincerus Florida, LLC (080105003)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
Sincerus Flo rida, LLC
0 8 0 10 50 0 3
ma nufa c ture (729 34-5151)
Revised: 5/2019